ストックスクリーナーアプリを入手
1.09
3.54%
-0.04
プレマーケット:
1.06
-0.03
-2.75%
Alaunos Therapeutics Inc (TCRT) 最新ニュース
Alaunos Therapeutics Inc (NASDAQ: TCRT) Share Price, TCRT Stock News, TCRT Share Price & Updates - kalkine.ca
Alaunos Therapeutics Announces New Registered Direct Offering - tipranks.com
Alaunos Therapeutics Enters Securities Purchase Agreement With Accredited Investors - TradingView
12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Alaunos Therapeutics prices registered direct offering to raise ~$1.12 million - TradingView
Alaunos Therapeutics raises $1.12M in registered direct offering By Investing.com - Investing.com Canada
Alaunos Therapeutics raises $1.12M in registered direct offering - Investing.com
Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules - The Manila Times
TCRT Stock Pops On Volatile Spike As Traders Circle - StocksToTrade
TCRT Stock Spikes On Heavy Volume As Traders Hunt Volatility - timothysykes.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
TCRT Stock Jumps As Traders Zero In On Volatility - StocksToTrade
$Alaunos Therapeutics (TCRT.US)$ - Moomoo
Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Alaunos Therapeutics (TCRT) Stock Soars Over 29% After-Hours: Here's What's Going On - Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Alaunos Therapeutics Updates Bylaws to Ease Shareholder Quorum - TipRanks
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Alaunos Therapeutics (TCRT) Holds Firm at $1.56 as Buyers Defend the Lower RangeMoving Average Crossovers - siam.in
Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportMcClellan Oscillator - siam.in
Alaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the DayCall Resistance - vinanet.vn
Alaunos Therapeutics Reports Encouraging Early Obesity Drug Results - Stocktwits
Alaunos (TCRT) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Market Move: The Stock Closes Near Unchanged in the Latest SessionAnnual Report - vinanet.vn
Alaunos (TCRT) EPS and Revenue: EPS Does Not Reach the Reported Estimate; Price Reaction: The Session Ends Near the Prior LevelAnalyst Coverage Count - vinanet.vn
Ziopharm: Q2 Earnings Snapshot - KTVB
Alaunos Therapeutics, Inc. Q2 2026: Revenue $0K, Net loss $988K, EPS $(0.41) — 10-Q Summary - TradingView
Alaunos Therapeutics (TCRT) warns on cash runway, Nasdaq compliance and losses - Stock Titan
Alaunos Therapeutics (TCRT) CEO granted 4,363 shares in lieu of cash salary - Stock Titan
Alaunos Therapeutics (TCRT) Holds Flat at $1.99 as Key Support and Resistance Levels Come into FocusStrangle Setup - dars.gov.et
Enterprise value to EBITDA forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
Alaunos Therapeutics Inc (TCRT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Alaunos Therapeutics (TCRT) Shows Modest Decline Amid Tight Range TradingVolume Breakout Ideas - careplusvn.com
CEO Holger Weis takes Alaunos Therapeutics, Inc. (TCRT) stock instead of salary - Stock Titan
Alaunos Therapeutics, Inc. (TCRT) director receives 8,138-share board fee grant - Stock Titan
Alaunos Therapeutics (TCRT) director gets 8,789-share equity grant in lieu of fees - Stock Titan
Alaunos Therapeutics (TCRT) director granted 8,463 shares for board fees - Stock Titan
Alaunos Therapeutics Inc (TCRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alaunos Therapeutics Inc (TCRT) Cash Flow - TradingKey
Alaunos Therapeutics Inc (TCRT) Balance Sheet - TradingKey
Alaunos Therapeutics Inc (TCRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Alaunos Therapeutics Inc (TCRT) Institutional Confidence - TradingKey
Alaunos Therapeutics, Inc. Revenue Breakdown – NASDAQ:TCRT - TradingView
Alaunos Therapeutics Inc (TCRT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TCRT|Alaunos Therapeutics Inc|Price:1.940|Chg%:+0.020 - TradingKey
Alaunos Therapeutics Inc (TCRT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alaunos Therapeutics (TCRT) Edges Higher as Stock Holds Above Key SupportMACD Signal Stocks - dars.gov.et
Price to earnings forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
TCRT Q4 2023 Earnings: EPS Misses Estimates Amid Ongoing Clinical FocusRevenue Report - vinanet.vn
Price to book forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
Enterprise value to revenue forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
Price to sales forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
TCRT Q4 2023 Earnings: Deeper-than-Expected Loss Weighs on Clinical-Stage BiotechMargin Compression Risk - dars.gov.et
Alaunos Therapeutics Inc. (TCRT) Q4 2023 Earnings: EPS Misses Expectations as Pre‑Revenue Biotech Struggles - dars.gov.et
TCRT Q4 2023 Earnings: Alaunos Therapeutics Misses EPS Expectations, Stock Declines as Pipeline Progress Remains KeyEarnings Quality Analysis - dars.gov.et
MSN Money - MSN
Form 4 Alaunos Therapeutics Inc For: 2 July By Investing.com - Investing.com Canada
Stock grant to Alaunos (TCRT) CEO issued in lieu of salary - Stock Titan
Alaunos Therapeutics Inc (TCRT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TCRT Q4 2023 Earnings: Miss on EPS as Alaunos Continues Pre-Clinical DevelopmentEarnings Per Share - dars.gov.et
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver - The National Law Review
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study - markets.businessinsider.com
Alaunos Reports New Preclinical Liver Data for ALN1003 - TipRanks
Alaunos Therapeutics (TCRT) posts new ALN1003 mouse liver and metabolic findings - Stock Titan
12 Health Care Stocks Moving In Monday's Pre-Market SessionUniverse Pharmaceuticals (NASDAQ:UPC), Deco - Benzinga
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):